| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Revenue | $4.80B | +20.1% |
| Cost of Revenue | $3.19B | +20.5% |
| Gross Profit | $1.61B | +19.4% |
| R&D Expense | $23.0M | +9.5% |
| SG&A Expense | $844.0M | +22.9% |
| Operating Income | $730.0M | -11.8% |
| Pre-tax Income | $579.0M | -19.0% |
| Income Tax | $80.0M | -38.5% |
| Net Income | $499.0M | -14.7% |
| EPS (Basic) | $2.74 | -13.0% |
| EPS (Diluted) | $2.73 | -12.2% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $449.0M | -49.9% |
| Accounts Receivable | $1.05B | +3.9% |
| Inventory | $702.0M | +24.7% |
| Current Assets | $2.92B | -0.0% |
| Total Assets | $10.51B | +15.3% |
| Current Liabilities | $1.10B | -8.2% |
| Long-term Debt | $4.17B | +31.7% |
| Line Item | 2022-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $439.0M | +1.4% |
| Capital Expenditures | $660.0M | -3.8% |
| Investing Cash Flow | -$1.88B | -190.3% |
| Financing Cash Flow | $1.03B | +626.1% |
| Free Cash Flow | -$221.0M | +12.6% |
| Total Liabilities |
| $5.73B |
| +18.5% |
| Stockholders' Equity | $4.78B | +22.0% |